Latest news from Memorial Sloan Kettering Cancer Center on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/new-rare-type-of-small-cell-lung-cancer-identified-by-msk-research-team/?sc=rsin /articles/new-rare-type-of-small-cell-lung-cancer-identified-by-msk-research-team/?sc=rsin Wed, 11 Sep 2024 15:05:40 EST A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story. Memorial Sloan Kettering Cancer Center /articles/mark-awad-named-chief-of-the-thoracic-oncology-service-at-memorial-sloan-kettering-cancer-center/?sc=rsin /articles/mark-awad-named-chief-of-the-thoracic-oncology-service-at-memorial-sloan-kettering-cancer-center/?sc=rsin Tue, 10 Sep 2024 09:00:00 EST Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). Memorial Sloan Kettering Cancer Center /articles/tgf-beta-and-ras-signaling-are-both-required-for-lung-cancer-metastasis-study-finds/?sc=rsin /articles/tgf-beta-and-ras-signaling-are-both-required-for-lung-cancer-metastasis-study-finds/?sc=rsin Fri, 06 Sep 2024 13:05:47 EST MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest. Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-september-3-2024/?sc=rsin /articles/msk-research-highlights-september-3-2024/?sc=rsin Tue, 03 Sep 2024 09:05:52 EST New research from Memorial Sloan Kettering Cancer Center (MSK) uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing. Memorial Sloan Kettering Cancer Center /articles/msk-awards-and-appointments-august-2024/?sc=rsin /articles/msk-awards-and-appointments-august-2024/?sc=rsin Fri, 30 Aug 2024 10:00:00 EST Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-august-13-2024/?sc=rsin /articles/msk-research-highlights-august-13-2024/?sc=rsin Tue, 13 Aug 2024 10:05:38 EST New research from Memorial Sloan Kettering Cancer Center (MSK) found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells. Memorial Sloan Kettering Cancer Center /articles/msk-awards-and-appointments-june-july-2024/?sc=rsin /articles/msk-awards-and-appointments-june-july-2024/?sc=rsin Thu, 01 Aug 2024 17:00:26 EST Memorial Sloan Kettering Cancer Center (MSK) announced the following awards and appointments. Memorial Sloan Kettering Cancer Center /articles/msk-research-highlights-july-31-2024/?sc=rsin /articles/msk-research-highlights-july-31-2024/?sc=rsin Wed, 31 Jul 2024 09:05:28 EST New research from Memorial Sloan Kettering Cancer Center (MSK) showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer. Memorial Sloan Kettering Cancer Center /articles/better-together-spatial-arrangement-of-three-immune-cells-is-key-to-attacking-tumors/?sc=rsin /articles/better-together-spatial-arrangement-of-three-immune-cells-is-key-to-attacking-tumors/?sc=rsin Mon, 15 Jul 2024 15:05:44 EST In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary -- a dendritic cell, a cytotoxic "killer" T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies. Memorial Sloan Kettering Cancer Center /articles/msk-discovery-suggests-opportunity-to-improve-effectiveness-of-kras-inhibitors-against-pancreatic-cancer/?sc=rsin /articles/msk-discovery-suggests-opportunity-to-improve-effectiveness-of-kras-inhibitors-against-pancreatic-cancer/?sc=rsin Fri, 12 Jul 2024 13:05:55 EST Researchers at Memorial Sloan Kettering Cancer Center (MSK) have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective. Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-celebrates-exceptional-service-in-nursing-2024-robbins-family-awards/?sc=rsin /articles/memorial-sloan-kettering-celebrates-exceptional-service-in-nursing-2024-robbins-family-awards/?sc=rsin Fri, 10 May 2024 12:05:42 EST Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 - 12). Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-cancer-center-launches-innovative-projects-to-improve-health-in-queens-and-brooklyn/?sc=rsin /articles/memorial-sloan-kettering-cancer-center-launches-innovative-projects-to-improve-health-in-queens-and-brooklyn/?sc=rsin Mon, 06 May 2024 09:05:13 EST Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member Bruce Ratner, the Ratner Early Detection Initiative (REDI) draws from MSK's deep experience in cancer science and discovery, community engagement, and compassionate patient care. Memorial Sloan Kettering Cancer Center /articles/jeffrey-drebin-md-phd-named-president-elect-of-the-american-surgical-association/?sc=rsin /articles/jeffrey-drebin-md-phd-named-president-elect-of-the-american-surgical-association/?sc=rsin Mon, 08 Apr 2024 11:05:54 EST Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Jeffrey A. Drebin, MD, PhD, has been named President-Elect of the American Surgical Association (ASA) for 2024. Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-awarded-prestigious-nci-grant-to-further-advance-car-t-cell-treatments-for-solid-tumors/?sc=rsin /articles/memorial-sloan-kettering-awarded-prestigious-nci-grant-to-further-advance-car-t-cell-treatments-for-solid-tumors/?sc=rsin Mon, 18 Mar 2024 15:05:35 EST A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors. Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-launches-bilingual-campaign-promoting-screenings-in-the-hispanic-community/?sc=rsin /articles/memorial-sloan-kettering-launches-bilingual-campaign-promoting-screenings-in-the-hispanic-community/?sc=rsin Mon, 05 Feb 2024 09:00:00 EST Today, Memorial Sloan Kettering Cancer Center (MSK), in collaboration with Miami-based creative agency Alma, launched a bilingual public service campaign to promote the importance of routine cancer screenings. Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-cancer-center-announces-landmark-400-million-gift-from-citadel-founder-and-ceo-kenneth-c-griffin/?sc=rsin /articles/memorial-sloan-kettering-cancer-center-announces-landmark-400-million-gift-from-citadel-founder-and-ceo-kenneth-c-griffin/?sc=rsin Tue, 12 Dec 2023 09:05:26 EST Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, and David Geffen, Founder of The David Geffen Foundation. Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-cancer-center-and-nmdpbe-the-match-launch-american-symphony-become-a-lifesaver-campaign/?sc=rsin /articles/memorial-sloan-kettering-cancer-center-and-nmdpbe-the-match-launch-american-symphony-become-a-lifesaver-campaign/?sc=rsin Wed, 29 Nov 2023 09:00:00 EST Memorial Sloan Kettering Cancer Center (MSK) and NMDP/Be The Match(r) today announced the launch of the "American Symphony: Become a Lifesaver" campaign to increase registration of blood stem cell and marrow donors to the national registry and improve access to blood stem cell transplants. Memorial Sloan Kettering Cancer Center /articles/three-investigators-named-winners-of-memorial-sloan-kettering-cancer-center-s-2023-paul-marks-prize-for-cancer-research/?sc=rsin /articles/three-investigators-named-winners-of-memorial-sloan-kettering-cancer-center-s-2023-paul-marks-prize-for-cancer-research/?sc=rsin Mon, 13 Nov 2023 12:05:14 EST The biennial prize recognizes a new generation of leaders in cancer research Memorial Sloan Kettering Cancer Center /articles/craig-d-blinderman-named-chief-of-supportive-care-service-at-memorial-sloan-kettering-cancer-center/?sc=rsin /articles/craig-d-blinderman-named-chief-of-supportive-care-service-at-memorial-sloan-kettering-cancer-center/?sc=rsin Wed, 01 Nov 2023 09:30:00 EST Craig D. Blinderman, MD, has been appointed Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSK). Memorial Sloan Kettering Cancer Center /articles/memorial-sloan-kettering-cancer-center-announces-visionary-gift-from-the-commonwealth-foundation-for-cancer-research/?sc=rsin /articles/memorial-sloan-kettering-cancer-center-announces-visionary-gift-from-the-commonwealth-foundation-for-cancer-research/?sc=rsin Wed, 13 Sep 2023 10:30:26 EST Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the Center for Experimental Therapeutics, a multidisciplinary research and drug development group at MSK. Memorial Sloan Kettering Cancer Center